QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
NASDAQ:BEAM

Beam Therapeutics - BEAM SEC Filings & 10K Form

$43.18
-1.19 (-2.68%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$42.15
$44.26
50-Day Range
$37.88
$51.60
52-Week Range
$27.77
$88.18
Volume
531,576 shs
Average Volume
1.12 million shs
Market Capitalization
$3.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$76.17

Recent Beam Therapeutics SEC Filings

DateFilerForm TypeView
11/07/2022
6:31 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2022
6:00 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2022
3:30 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2022
10:04 AM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2022
5:47 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2022
3:06 PM
Beam Therapeutics (Issuer)
Burow Kristina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2022
3:05 PM
Beam Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2022
6:08 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2022
6:31 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2022
6:00 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2022
3:49 PM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2022
5:50 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2022
6:33 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2022
6:01 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2022
5:51 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2022
3:29 PM
Beam Therapeutics (Filer)
Form DEFA14A
04/22/2022
3:24 PM
Beam Therapeutics (Filer)
Form DEF 14A
04/14/2022
4:13 PM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2021
5:05 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:24 PM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
6:46 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2021
5:46 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2021
5:00 PM
Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
5:00 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2021
3:11 PM
Beam Therapeutics (Filer)
Form 424B5
07/07/2021
3:01 PM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2021
5:01 PM
Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
5:00 PM
Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
5:00 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
5:00 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
5:00 PM
Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
4:22 PM
ARCH Venture Fund IX Overage, L.P. (Reporting)
ARCH Venture Fund IX, L.P. (Reporting)
ARCH Venture Partners IX Overage, L.P. (Reporting)
ARCH Venture Partners IX, L.P. (Reporting)
ARCH Venture Partners IX, LLC (Reporting)
Beam Therapeutics (Issuer)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
4:20 PM
Beam Therapeutics (Issuer)
Burow Kristina (Reporting)
Burow Kristina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
4:20 PM
Beam Therapeutics (Issuer)
Beam Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
8:11 PM
Beam Therapeutics (Reporting)
Verve Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2021
7:02 AM
Beam Therapeutics (Issuer)
Fishman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:57 AM
Beam Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:55 AM
Beam Therapeutics (Issuer)
Burow Kristina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:53 AM
Beam Therapeutics (Issuer)
Walsh Kathleen E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:52 AM
Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
12:14 PM
ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
Form SC 13G
06/10/2021
6:03 AM
Beam Therapeutics (Filer)
Form S-3ASR
05/24/2021
3:10 PM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2021
3:16 PM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2021
6:48 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2021
3:45 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2021
3:15 PM
Beam Therapeutics (Filer)
Form DEFA14A
04/12/2021
6:29 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:20 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:13 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:11 PM
Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
2:21 PM
Beam Therapeutics (Issuer)
Burow Kristina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
2:20 PM
Beam Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
2:19 PM
ARCH Venture Fund IX Overage, L.P. (Reporting)
ARCH Venture Fund IX, L.P. (Reporting)
ARCH Venture Partners IX Overage, L.P. (Reporting)
ARCH Venture Partners IX, L.P. (Reporting)
ARCH Venture Partners IX, LLC (Reporting)
Beam Therapeutics (Issuer)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
7:15 AM
Beam Therapeutics (Filer)
Form 424B5
04/01/2021
6:48 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2021
6:36 AM
Beam Therapeutics (Filer)
Form 424B7
04/01/2021
6:24 AM
Beam Therapeutics (Filer)
Form 424B7
04/01/2021
5:08 AM
Beam Therapeutics (Filer)
Form S-3ASR
03/22/2021
6:39 PM
Beam Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
6:37 PM
Beam Therapeutics (Issuer)
Burow Kristina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
6:34 PM
ARCH Venture Fund IX Overage, L.P. (Reporting)
ARCH Venture Fund IX, L.P. (Reporting)
ARCH Venture Partners IX Overage, L.P. (Reporting)
ARCH Venture Partners IX, L.P. (Reporting)
ARCH Venture Partners IX, LLC (Reporting)
Beam Therapeutics (Issuer)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
6:15 AM
Beam Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/15/2021
4:01 PM
Beam Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/15/2021
5:45 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
7:43 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2021
5:06 AM
Beam Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G
02/02/2021
3:13 PM
ARCH Venture Fund IX, L.P. (Filed by)
Beam Therapeutics (Subject)
Form SC 13G
02/01/2021
1:41 PM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
6:00 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
4:26 PM
Beam Therapeutics (Issuer)
Walsh Kathleen E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
4:19 PM
Beam Therapeutics (Issuer)
Walsh Kathleen E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2021
3:30 PM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
4:40 PM
Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
4:32 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
4:31 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
5:49 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/10/2020
5:41 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2020
4:49 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
3:21 PM
Beam Therapeutics (Filer)
Form 424B4
09/30/2020
11:15 PM
Beam Therapeutics (Filer)
Form EFFECT
09/28/2020
3:02 PM
Beam Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/21/2020
8:08 PM
Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2020
8:25 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
6:45 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2020
6:30 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2020
2:15 PM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:28 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
3:14 PM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2020
9:52 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2020
4:26 PM
Beam Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/30/2020
5:45 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
7:50 PM
Beam Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/12/2020
1:07 PM
Beam Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
02/12/2020
1:03 PM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:07 AM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:07 AM
Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:06 AM
Beam Therapeutics (Issuer)
Fishman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:04 AM
Beam Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:04 AM
Beam Therapeutics (Issuer)
Burow Kristina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:BEAM) was last updated on 12/6/2022 by MarketBeat.com Staff